Sarah Spence
Family · Murfreesboro, TNNPI 1376082990
Payments from drug & device makers
Across 371 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novo Nordisk$999
- AbbVie$547
- Insulet Corporation$440
- Cequr Corporation$359
- Medtronic$357
- plus $4K from 34 others
What the payments were for
- Food & beverage$7,534100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 66 | $1,229 |
| Novo Nordisk | 59 | $999 |
| AbbVie(2 entities) | 29 | $547 |
| Insulet Corporation | 17 | $440 |
| Cequr Corporation | 3 | $359 |
| Medtronic | 11 | $357 |
| Amgen | 22 | $341 |
| Xeris Pharmaceuticals, Inc. | 21 | $322 |
| Dexcom, Inc. | 22 | $313 |
| AstraZeneca | 9 | $282 |
| Boehringer Ingelheim | 14 | $241 |
| Tandem Diabetes Care, Inc. | 6 | $218 |
| Abbott | 13 | $215 |
| Sanofi-aventis U.S. LLC | 9 | $207 |
| Antares Pharma, Inc. | 10 | $193 |
| Mannkind Corporation | 9 | $180 |
| BETA Bionics, Inc. | 4 | $163 |
| Bayer | 7 | $132 |
| Corcept Therapeutics | 3 | $130 |
| Ascendis Pharma Endocrinology Inc | 3 | $62 |
| Zealand Pharma US, Inc. | 2 | $56 |
| Radius Health, Inc. | 3 | $55 |
| IBSA Pharma Inc. | 3 | $48 |
| Amneal Pharmaceuticals LLC | 3 | $44 |
| Tolmar, Inc. | 3 | $43 |
| Exeltis, USA Inc. | 2 | $39 |
| UCB, Inc. | 2 | $37 |
| Abiomed | 1 | $37 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $32 |
| Sequel Med Tech, LLC | 1 | $28 |
| Merck | 2 | $25 |
| Nevro Corp. | 1 | $17 |
| Halozyme Inc | 1 | $17 |
| Biogen | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Pfizer | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$269
- RYBELSUS$104
How this compares
$7,534 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 295 | $451,419 |
| JardianceEmpagliflozin | 126 | $172,633 |
| OzempicSemaglutide | 90 | $150,373 |
| TrulicityDulaglutide | 74 | $131,866 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 62 | $94,834 |
| Tresiba Flextouch U-200Insulin Degludec | 62 | $89,571 |
| Tresiba Flextouch U-100Insulin Degludec | 92 | $66,240 |
| TymlosAbaloparatide | 15 | $41,280 |
| FarxigaDapagliflozin Propanediol | 46 | $40,523 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $31,745 |
| JanuviaSitagliptin Phosphate | 17 | $27,256 |
| Xigduo XrDapaglifloz Propaned/Metformin | 25 | $27,165 |
| Novolog FlexpenInsulin Aspart | 88 | $25,756 |
| RybelsusSemaglutide | 21 | $23,369 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 11 | $18,464 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,229 | $596,489416 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $241 | $191,097137 claims |
| Novo NordiskOzempic, Rybelsus, Novolog, Tresiba | $999 | $188,735153 claims |
| Radius Health, Inc.Tymlos | $55 | $41,28015 claims |
| AstraZenecaFarxiga | $282 | $40,52346 claims |
| MerckJanuvia | $25 | $27,25617 claims |
| AbbVieSynthroid | $547 | $8,70582 claims |
| IBSA Pharma Inc.Tirosint, Tirosint-Sol | $48 | $8,45728 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $44 | $3,303358 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.
Other family in Murfreesboro
- Cynthia MillerMurfreesboro$384K
- Melanie McGheeMurfreesboro$48K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.